Literature DB >> 22966305

Abundance of a distinct cluster of telomere t-stumps in advanced breast cancer cell line.

Rekha B Pai1, S Balakrishna Pai, Lily Yang, Harish C Joshi.   

Abstract

Breast tumors are the second major cause of cancer-related death in women worldwide. These tumors are aggressive, leading to metastatic cancers that are heterogeneous in nature, with numerous subtypes. The basal-like tumor subtype invariably shows unfavorable prognosis and is often characterized by the lack of estrogen, progesterone and HER2 receptors. These cancer types do not respond to the current targeted therapies. Therefore, the need for the discovery of novel diagnostic markers/therapeutic targets is of paramount importance. Immortalization of breast tumor cells leading to advanced stage cancer is one of the pivotal steps in breast cancer and telomeres/telomerase play a critical role in this process. Using single telomere length analysis, cell lines with a basal-like phenotype encompassing immortalized/non-tumorigenic MCF10A and invasive/metastatic MCF10CA1 along with the MCF-7 cell line were examined for the presence of a unique class of telomere t-stumps. Telomerase activity, protein levels of telomerase and bulk telomere lengths were assessed in the above-mentioned cell lines. This is the first study describing the existence of a distinct class of extremely short telomeres termed 't-stumps' in breast cancer cell lines. The cell lines MCF10A and MCF10CA1 showed distinct telomeric bands in the molecular size range of 100-1,000 bp, whereas the MCF-7 cell line showed very low levels of t-stumps. Of note is that only the highly invasive/metastatic cancer cell line MCF10CA1 exhibited an abundance of a cluster of t-stumps with a size distribution range of 500-700 bp. These unique t-stumps observed in the advanced breast cancer cell line may serve as a novel diagnostic marker and also form a key molecular target for novel anticancer therapy.

Entities:  

Year:  2010        PMID: 22966305      PMCID: PMC3436360          DOI: 10.3892/ol_00000060

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  20 in total

1.  A DNA damage checkpoint response in telomere-initiated senescence.

Authors:  Fabrizio d'Adda di Fagagna; Philip M Reaper; Lorena Clay-Farrace; Heike Fiegler; Philippa Carr; Thomas Von Zglinicki; Gabriele Saretzki; Nigel P Carter; Stephen P Jackson
Journal:  Nature       Date:  2003-11-05       Impact factor: 49.962

2.  Early replication of short telomeres in budding yeast.

Authors:  Alessandro Bianchi; David Shore
Journal:  Cell       Date:  2007-03-23       Impact factor: 41.582

3.  Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.

Authors:  Rodrigo T Calado; Joshua A Regal; Mark Hills; William T Yewdell; Leandro F Dalmazzo; Marco A Zago; Peter M Lansdorp; Donna Hogge; Stephen J Chanock; Elihu H Estey; Roberto P Falcão; Neal S Young
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-15       Impact factor: 11.205

4.  Short telomeres are preferentially elongated by telomerase in human cells.

Authors:  Bethan Britt-Compton; Rebecca Capper; Jan Rowson; Duncan M Baird
Journal:  FEBS Lett       Date:  2009-08-29       Impact factor: 4.124

Review 5.  A survey of telomerase activity in human cancer.

Authors:  J W Shay; S Bacchetti
Journal:  Eur J Cancer       Date:  1997-04       Impact factor: 9.162

6.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

7.  Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening.

Authors:  J Zhu; H Wang; J M Bishop; E H Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

8.  Triple-negative breast cancer types exhibit a distinct poor clinical characteristic in lymph node-negative Chinese patients.

Authors:  Zhe-Bin Liu; Guang-Yu Liu; Wen-Tao Yang; Gen-Hong Di; Jin-Song Lu; Kun-Wei Shen; Zhen-Zhou Shen; Zhi-Min Shao; Jiong Wu
Journal:  Oncol Rep       Date:  2008-10       Impact factor: 3.906

9.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

10.  Short telomeres initiate telomere recombination in primary and tumor cells.

Authors:  Tammy A Morrish; Carol W Greider
Journal:  PLoS Genet       Date:  2009-01-30       Impact factor: 5.917

View more
  3 in total

Review 1.  Single-Run Catalysis and Kinetic Control of Human Telomerase Holoenzyme.

Authors:  Qiu-Xing Jiang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

2.  Three-dimensional Nuclear Telomere Organization in Multiple Myeloma.

Authors:  Ludger Klewes; Rhea Vallente; Eric Dupas; Carolin Brand; Dietrich Grün; Amanda Guffei; Chirawadee Sathitruangsak; Julius A Awe; Alexandra Kuzyk; Daniel Lichtensztejn; Pille Tammur; Tiiu Ilus; Anu Tamm; Mari Punab; Morel Rubinger; Adebayo Olujohungbe; Sabine Mai
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

Review 3.  Telomere Homeostasis: Interplay with Magnesium.

Authors:  Donogh Maguire; Ognian Neytchev; Dinesh Talwar; Donald McMillan; Paul G Shiels
Journal:  Int J Mol Sci       Date:  2018-01-05       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.